Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1988 1
1992 1
1993 1
1994 2
1995 2
1996 4
1997 7
1998 2
1999 6
2000 1
2001 6
2002 3
2003 7
2004 7
2005 7
2006 10
2007 11
2008 7
2009 10
2010 4
2011 3
2012 1
2013 5
2014 2
2017 4
2019 1
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.
Wang CY, Hwang KP, Kuo HK, Peng WJ, Shen YH, Kuo BS, Huang JH, Liu H, Ho YH, Lin F, Ding S, Liu Z, Wu HT, Huang CT, Lee YJ, Liu MC, Yang YC, Lu PL, Tsai HC, Lee CH, Shi ZY, Liu CE, Liao CH, Chang FY, Chen HC, Wang FD, Hou KL, Cheng J, Wang MS, Yang YT, Chiu HC, Jiang MH, Shih HY, Shen HY, Chang PY, Lan YR, Chen CT, Lin YL, Liang JJ, Liao CC, Chou YC, Morris MK, Hanson CV, Guirakhoo F, Hellerstein M, Yu HJ, King CC, Kemp T, Heppner DG, Monath TP. Wang CY, et al. Among authors: heppner dg. J Clin Invest. 2022 May 16;132(10):e157707. doi: 10.1172/JCI157707. J Clin Invest. 2022. PMID: 35316221 Free PMC article. Clinical Trial.
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.
Wang S, Wang CY, Kuo HK, Peng WJ, Huang JH, Kuo BS, Lin F, Liu YJ, Liu Z, Wu HT, Ding S, Hou KL, Cheng J, Yang YT, Jiang MH, Wang MS, Chen T, Xia WG, Lin E, Hung CH, Chen HJ, Shih Z, Lin YL, Ryan V, Hu MM, Heppner DG, Malherbe DC, Periasamy S, Kuzmina N, Subramani C, Hellerstein M, Monath TP, Rumyantsev A, Bukreyev A, Guirakhoo F. Wang S, et al. Among authors: heppner dg. Emerg Microbes Infect. 2022 Dec;11(1):2724-2734. doi: 10.1080/22221751.2022.2140608. Emerg Microbes Infect. 2022. PMID: 36287714 Free PMC article.
The malaria vaccine--status quo 2013.
Heppner DG. Heppner DG. Travel Med Infect Dis. 2013 Jan-Feb;11(1):2-7. doi: 10.1016/j.tmaid.2013.01.006. Epub 2013 Feb 28. Travel Med Infect Dis. 2013. PMID: 23454205 Review.
The threat of infectious diseases in Somalia.
Heppner DG Jr, Magill AJ, Gasser RA Jr, Oster CN. Heppner DG Jr, et al. N Engl J Med. 1993 Apr 8;328(14):1061-8. doi: 10.1056/NEJM199304083281430. N Engl J Med. 1993. PMID: 8450874 Free article. Review. No abstract available.
Human ehrlichiosis in Thailand.
Heppner DG, Wongsrichanalai C, Walsh DS, McDaniel P, Eamsila C, Hanson B, Paxton H. Heppner DG, et al. Lancet. 1997 Sep 13;350(9080):785-6. doi: 10.1016/S0140-6736(05)62571-8. Lancet. 1997. PMID: 9298007 No abstract available.
Malaria vaccines: triumphs or tribulations?
Ballou WR, Kester KE, Stoute JA, Heppner DG. Ballou WR, et al. Among authors: heppner dg. Parassitologia. 1999 Sep;41(1-3):403-8. Parassitologia. 1999. PMID: 10697893 Review.
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
Heppner DG Jr, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J. Heppner DG Jr, et al. Vaccine. 2005 Mar 18;23(17-18):2243-50. doi: 10.1016/j.vaccine.2005.01.142. Vaccine. 2005. PMID: 15755604 Review.
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
Coller BG, Blue J, Das R, Dubey S, Finelli L, Gupta S, Helmond F, Grant-Klein RJ, Liu K, Simon J, Troth S, VanRheenen S, Waterbury J, Wivel A, Wolf J, Heppner DG, Kemp T, Nichols R, Monath TP. Coller BG, et al. Among authors: heppner dg. Vaccine. 2017 Aug 16;35(35 Pt A):4465-4469. doi: 10.1016/j.vaccine.2017.05.097. Epub 2017 Jun 21. Vaccine. 2017. PMID: 28647166
112 results